| Miss Trisha Ellen Kiliany, CRNA | |
|
10 Wayman Ln, Bar Harbor, ME 04609-1625 | |
| (207) 288-5081 | |
| Not Available |
| Full Name | Miss Trisha Ellen Kiliany |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 27 Years |
| Location | 10 Wayman Ln, Bar Harbor, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508836685 | NPI | - | NPPES |
| 367500000X | Medicaid | WA | |
| G8898257 | Other | WA | MDCR PTAN (K) |
| RNA243002 | Other | ME | MAINE BOARD OF NURSING |
| G8912171 | Other | WA | MDCR PTAN (P) |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Gastroenterology Pllc | 6204194848 | 115 |
News Archive
A group of French scientists have published a paper in the Canadian Medical Association Journal (CMAJ) on guidelines for drinking and the relation of alcohol to cancer.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
› Verified 5 days ago
| Entity Name | Pacific County Hospital District 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295708683 PECOS PAC ID: 8224939301 Enrollment ID: O20040120000991 |
News Archive
A group of French scientists have published a paper in the Canadian Medical Association Journal (CMAJ) on guidelines for drinking and the relation of alcohol to cancer.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
› Verified 5 days ago
| Entity Name | Public Hospital District 3 Of Pacific County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295771376 PECOS PAC ID: 7214822105 Enrollment ID: O20040219000157 |
News Archive
A group of French scientists have published a paper in the Canadian Medical Association Journal (CMAJ) on guidelines for drinking and the relation of alcohol to cancer.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
› Verified 5 days ago
| Entity Name | Paceline Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417273780 PECOS PAC ID: 5799853099 Enrollment ID: O20081013000526 |
News Archive
A group of French scientists have published a paper in the Canadian Medical Association Journal (CMAJ) on guidelines for drinking and the relation of alcohol to cancer.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
› Verified 5 days ago
| Entity Name | Washington Gastroenterology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306364401 PECOS PAC ID: 6204194848 Enrollment ID: O20180103000884 |
News Archive
A group of French scientists have published a paper in the Canadian Medical Association Journal (CMAJ) on guidelines for drinking and the relation of alcohol to cancer.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Trisha Ellen Kiliany, CRNA 4810 Point Fosdick Dr Nw, Box #224, Gig Harbor, WA 98335-1711 Ph: (360) 402-5767 | Miss Trisha Ellen Kiliany, CRNA 10 Wayman Ln, Bar Harbor, ME 04609-1625 Ph: (207) 288-5081 |
News Archive
A group of French scientists have published a paper in the Canadian Medical Association Journal (CMAJ) on guidelines for drinking and the relation of alcohol to cancer.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
› Verified 5 days ago
Paula Kay Lavigne, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10 Wayman Ln, Bar Harbor, ME 04609 Phone: 207-661-2018 | |
Rachael F Sharp, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10 Wayman Ln, Mount Desert Island Hospital, Bar Harbor, ME 04609 Phone: 207-288-5081 Fax: 207-288-7024 | |
William Cash Byer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10 Wayman Ln, Bar Harbor, ME 04609 Phone: 207-288-5081 | |
Mr. Ralph A Erickson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 10 Wayman Ln, Bar Harbor, ME 04609 Phone: 207-288-5081 Fax: 207-288-7024 | |
Mr. Christopher W Price, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 10 Wayman Ln, Mount Desert Island Hospital, Bar Harbor, ME 04609 Phone: 207-288-5081 Fax: 207-288-8600 | |
Katelynn Elizabeth Badger, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 10 Wayman Ln, Bar Harbor, ME 04609 Phone: 207-288-5081 Fax: 207-288-8620 | |
Mr. Thomas J Giannaccini Iii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10 Wayman Ln, Bar Harbor, ME 04609 Phone: 207-288-5081 |